FDA Inspection
Apex Pharmaceuticals Inc.FDA Inspection 1086635 - Apex Pharmaceuticals Inc. - April 18, 2019
Record Details
This FDA Inspection record concerns Apex Pharmaceuticals Inc., with an inspection on April 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · acd2cd41-87e3-4b8f-ae9f-2ba918d9aa96
Violation Codes3
21 CFR 211.160(b)21 CFR 211.25(a)21 CFR 211.67(a)
Full citation text and observation details available on the Dashboard.